| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 10/10/2001 | EP0793476B1 Use of Mangiferin or Derivatives thereof for Cosmetic Applications |
| 10/09/2001 | US6300499 α1-adrenergic receptor antagonists |
| 10/09/2001 | US6300350 Administering to mammal an retinoic acid (rar) agonist that is at least gamma selective and is rar.alpha. sparing for treating emphysema |
| 10/09/2001 | CA2218306C Method of preventing allograft rejection |
| 10/09/2001 | CA2161297C Novel diosmetin derivatives; process for preparing the same and pharmaceutical_compositions containing them |
| 10/04/2001 | WO2001072735A2 Benzopyranes useful as tnf alpha inhibitors |
| 10/04/2001 | WO2001072301A1 Intracorporeal medicaments for photodynamic treatment of disease |
| 10/04/2001 | WO2001072291A2 Treatment of movement disorders with metabotropic glutamate receptor antagonist |
| 10/04/2001 | WO2001021577A3 Melanin concentrating hormone antagonist |
| 10/04/2001 | US20010027255 Tocopherol manufacture by tris(perfluorohydrocarbylsulphonyl) methane or metal methides thereof |
| 10/04/2001 | US20010027210 Administering a synergistic mixture of a compound of the xanthenone acetic acid class (5,6-dimethylxanthenone-4-acetic acid) and either paclitaxel or docetaxel; antitumor and -carcinogenic agents |
| 10/04/2001 | US20010026814 Composition for and method of reducing low density lipoprotein cholesterol concentration |
| 10/04/2001 | US20010025948 Photochromic article |
| 10/04/2001 | EP1138682A1 Novel water soluble c-ring analogues of 20 (s)-camptothecin |
| 10/04/2001 | EP1137429A2 Bioflavonoids, anthocyanins and phenolic compounds from cherries for inhibiting inflammation |
| 10/04/2001 | DE10016449A1 Production of silymarin from Silybum marianum seeds includes defatting of powdered seeds with hydrocarbon solvent, extraction with acetonitrile and purification using dichloromethane |
| 10/04/2001 | DE10012962A1 Verfahren zur Parallelsynthese von mindestens zwei organischen Farbstoffen sowie substituierte Cumarinderivate und Arylboronsäurepropandiolester A method for parallel synthesis of at least two organic dyes and substituted coumarin derivatives and Arylboronsäurepropandiolester |
| 10/04/2001 | CA2404049A1 Treatment of movement disorders |
| 10/04/2001 | CA2402187A1 Intracorporeal medicaments comprising halogenated xanthene for photodynamic treatment of disease |
| 10/03/2001 | CN1315948A Naphthopyrans annelated in C5-C6, their preparation and compositions and (CO) polymer matrices containing them |
| 10/03/2001 | CN1315947A Preparation of tocopherols |
| 10/03/2001 | CN1315936A Compounds and compositions for delivering active agents |
| 10/03/2001 | CN1315325A Process for producing alpha-tocopheryl acetate |
| 10/03/2001 | CN1315324A Process for separating compound anisodus luridus from plant Artemisia annua |
| 10/03/2001 | CN1315323A Process for extracting glycitin and soybean saponin |
| 10/03/2001 | CN1315322A Process for extracting glycitin and soybean saponin |
| 10/03/2001 | CN1072217C Process for producing 2-substituted-3,4-condensed heterocyclic benzoic acid |
| 10/02/2001 | US6297273 Use of cocoa solids having high cocoa polyphenol content in tabletting compositions and capsule filling compositions |
| 10/02/2001 | US6296785 Ophthalmic and contact lenses; windows, safety glass for cars |
| 09/27/2001 | WO2001070719A2 Hydroxylated/carboxylated naphthopyrans |
| 09/27/2001 | WO2001070668A2 Amines substituted with a dihydronaphthalenyl, crhomenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 09/27/2001 | WO2001070662A2 2,4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 09/27/2001 | WO2001017972A3 Novel herbicides |
| 09/27/2001 | US20010025105 Anticancer agent; Alzheimer's therapy |
| 09/27/2001 | US20010025036 Modifying the structure of a 1alpha-hydroxylated vitamin D compound to increase its in vivo activity by altering the conformational equilibrium of the A-ring to favor a chair conformation that presents 1alphahydroxy in axial orientation |
| 09/27/2001 | US20010025035 Water soluble prodrugs of hindered alcohols |
| 09/27/2001 | US20010024810 Libraries of polyketides synthesized by a multiplicity of polyketide synthases that are derived from naturally occuring synthases that contain regions that encode enzymatic activities and scaffolding amino acid sequences |
| 09/27/2001 | US20010024798 Biomimetic combinatorial synthesis |
| 09/27/2001 | US20010024749 Surface modified carbonaceous materials |
| 09/27/2001 | US20010024666 Composition for and method of reducing low density lipoprotein cholesterol concentration |
| 09/27/2001 | CA2403805A1 Amines substituted with a dihydronaphthalenyl, crhomenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 09/26/2001 | EP1136080A2 Use of o-vanillin and o-vanillin/trolox combinations |
| 09/26/2001 | EP1135995A2 Composition and method for stabilising proanthocyanidin |
| 09/26/2001 | EP1135142A1 Production of a product enriched in isoflavone values from natural sources |
| 09/26/2001 | EP1095001A4 Method of vitamin production |
| 09/26/2001 | EP0934252B1 Amide derivatives and their use as pesticides |
| 09/26/2001 | EP0725778B1 Recombinant production of novel polyketides |
| 09/26/2001 | CN1314902A Process for preparing 3-isochromanone |
| 09/26/2001 | CN1314901A Methods for separating tocol from tocol-containing mixture |
| 09/26/2001 | CN1314354A Process for preparing (fully racemic)-alpha-tocopherol |
| 09/26/2001 | CN1314353A Method for super critical fluid extraction and concentration of natural vitamine E |
| 09/26/2001 | CN1314352A Soya aglycone-3'-sodium sulfonate and its preparing method and medicinal use |
| 09/26/2001 | CN1071738C Carboxylic derivatives exhibiting phospholipase A2 inhibitory activity |
| 09/25/2001 | US6294580 For therapy and prophylaxis of type ii or non-insulin dependent diabetes mellitus, hyperglycaemia, dyslipidemia, type ii diabetes, type i diabetes, hypertriglyceridemia, syndrome x, insulin resistance, heart failure |
| 09/25/2001 | US6294504 Antidotes for herbicides |
| 09/25/2001 | US6294390 Compound consisting of ionophore, fluorophore, and a functional group bound together through a trivalent organic radical; sensors having long usable life and a high degree of sensitivity |
| 09/25/2001 | US6294190 Antiobestic agent containing procyanidin as the active ingredient |
| 09/25/2001 | US6294112 Red coloring hyperchromic 3H-naphtho[2,1-B]pyrans |
| 09/25/2001 | CA2213404C Use of angiogenesis suppressors for inhibiting hair growth |
| 09/24/2001 | CA2341618A1 Proanthocyanidin-containing composition |
| 09/20/2001 | WO2001068635A2 Parallel synthesis method for at least two organic colorants and substituted coumarin derivatives and aryl boronic acid and arylboronic acid propanediol esters |
| 09/20/2001 | WO2001068634A1 4-fluoroalkyl-2h-benzopyrans with anti-estrogenic activity |
| 09/20/2001 | WO2001068593A2 Amino acid derivatives as hiv aspartyl protease inhibitors |
| 09/20/2001 | WO2001068585A1 Novel amide compounds |
| 09/20/2001 | WO2001068071A2 Use of natural chrysanthone compounds having antiangiogenic activity |
| 09/20/2001 | WO2001034591A3 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/20/2001 | US20010022970 Halogenated xanthan compound |
| 09/20/2001 | DE10013167A1 Cosmetic or dermatological skin treatment composition containing ascorbic acid or derivative, stabilized by combination of polyphenol, lipophilic antioxidant and basic nitrogen compound |
| 09/20/2001 | CA2401821A1 Amino acid derivatives as hiv aspartyl protease inhibitors |
| 09/20/2001 | CA2401267A1 Use of natural compounds having antiangiogenic activity |
| 09/19/2001 | EP1134218A1 Process for manufacturing (all-rac.)-alpha-Tocopherol |
| 09/19/2001 | EP1133688A1 Method of preparing delta-9-tetrahydrocannabinol |
| 09/19/2001 | EP1133498A2 Amino-and mercurio-substituted 4', 5'-dihydropsoralens and therapeutical uses thereof |
| 09/19/2001 | CN1313846A C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cystenine proteases |
| 09/19/2001 | CN1313765A Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents |
| 09/19/2001 | CN1313285A Process of extracting total flavone from grap seeds |
| 09/18/2001 | US6291693 Used in assays for the presence of vitamin d, vitamin d analogs and their metabolites which may be present in milk, blood or other biological fluids |
| 09/18/2001 | US6291677 Compounds having activity as inhibitors of cytochrome P450RAI |
| 09/18/2001 | US6291561 For producing lenses which are used in glazing, optical device, or ophthalmic or solar article |
| 09/18/2001 | US6291518 Hydroxy and polyhydroxy derivatives of coumarin, preparation thereof and antiviral action thereof |
| 09/18/2001 | US6291464 Aminopiperazine derivatives |
| 09/18/2001 | US6291456 Compounds and methods for modulation of estrogen receptors |
| 09/18/2001 | US6291399 Agent for controlling diseases and insect pests, containing alkoxyimino-substituted bicyclic derivative as active ingredient |
| 09/17/2001 | CA2340518A1 Process for manufacturing (all-rac.)-.alpha.-tocopherol |
| 09/14/2001 | CA2340549A1 Use of a methoxysalicylaldehyde derivative for stabilizing a solid-state protein |
| 09/13/2001 | WO2001066783A1 Novel 7,8-dihydro-xanthenone-8-carboxylic acid derivative and novel microbe producing the same |
| 09/13/2001 | WO2001066538A1 A process for purifying lovastatin and simvastatin with reduced levels of dimeric impurities |
| 09/13/2001 | WO2001066077A1 Use of 4-oxoretinol and derivatives thereof in cosmetic preparations |
| 09/13/2001 | US20010021780 Anticonvulsants, psychological disorders |
| 09/13/2001 | US20010021710 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 09/13/2001 | DE10011403A1 Production of alpha-tocopherol acetate useful as feed additive involves condensation of trimethylhydroquinone and isophytol in presence of a regenerable catalyst system followed by acylation of the resultant alpha-tocopherol |
| 09/13/2001 | DE10011402A1 Verfahren zur Herstellung von alpha-Tocopherolestern A process for preparing alpha-tocopherol |
| 09/13/2001 | DE10010814A1 Cosmetic preparations containing new or known 4-oxoretinol compounds, useful for prophylaxis of aging of the skin or hair |
| 09/13/2001 | CA2402061A1 A process for purifying lovastatin and simvastatin with reduced levels of dimeric impurities |
| 09/12/2001 | EP1132385A2 Process for the production of alfa-tocopherolacetate by condensation of trimethylhydroquinone-diesters with isophytol |
| 09/12/2001 | EP1132384A2 Process for the production of alpha-tocopherol acetate by condensation of trimethylhydroquinone with isophytol |
| 09/12/2001 | EP0888317B1 Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma |
| 09/12/2001 | EP0839142B1 A novel asymmetric synthesis of r and s warfarin and its analogs |
| 09/12/2001 | CN1312803A Novel benzopykan or thiobenzopyran derivatives |
| 09/12/2001 | CN1312718A Selective estrogen receptor modulator in combination with sex steriod precursors and the like |